Skip to main content


Latest articles

22-06-2021 | Oncology | News | Article

COVID-19: Remote patient monitoring proves effective for outpatient management

A randomized trial and a cross-sectional analysis have found that remote patient monitoring had a positive impact on people with cancer during the COVID-19 pandemic, while a survey suggests that patients also find the approach favorable.

21-06-2021 | Oncology | News | Article

Bacterial product linked to improved metastatic RCC response to nivolumab plus ipilimumab

Preliminary research presented at the 2021 ASCO Annual Meeting suggests that use of a bacterial product might improve response to checkpoint inhibitor therapy in patients with metastatic renal cell carcinoma.

17-06-2021 | Oncology | News | Article

Five-year KEYNOTE-045 update confirms pembrolizumab benefit in advanced UC

Updated results from the phase 3 KEYNOTE-045 trial show that pembrolizumab monotherapy continues to be associated with improved long-term outcomes relative to chemotherapy in advanced urothelial cancer patients who have progressed on platinum-based chemotherapy.

This independent news story was supported by an educational grant from Pfizer and Merck Healthcare KGaA, Darmstadt, Germany

16-06-2021 | Oncology | News | Article

Immunotherapy linked to improved metastatic small-cell urothelial cancer survival

Treatment with immune checkpoint inhibitors may improve the overall survival of people with metastatic small-cell urothelial cancer, suggests a chart review.

16-06-2021 | Oncology | News | Article

QoL maintained with enfortumab vedotin in advanced urothelial carcinoma

The quality of life data from the phase 3 EV-301 study add support for the use of enfortumab vedotin in previously treated patients with advanced urothelial carcinoma.

14-06-2021 | Oncology | News | Article

Benefit of second-line vinorelbine in malignant mesothelioma shown in VIM trial

Results from the phase 2 VIM trial support the use of vinorelbine in patients with malignant pleural mesothelioma whose disease has progressed following platinum-based therapy.

Image Credits